Antitumor effects of the selective cycloxygenase-1 inhibitor SC-560 is potentiated by inhibition of MEK/ERK pathway in human hepatocellular cells.

Research output: Contribution to conferenceOther

Original languageUndefined/Unknown
PagesS50-S50
Publication statusPublished - 2005

Cite this